Solage
Drug - Solage
The trade name of the product as shown on the labeling.
Dosage -
SOLUTION; TOPICAL
The product dosage form and route separated by a semi-colon.
Active Ingredient(s) -
Mequinol; Tretinoin
Multiple ingredients are in alphabetical order.
Strength -
2%;0.01%
The potency of the active ingredient(s), Mequinol; Tretinoin. May repeat for multiple part products.
Applicant -
BARRIER
The firm name holding legal responsibility for Solage. The firm name is condensed to a maximum twenty character unique string.
New Drug Application (NDA) Number -
020922
The FDA assigned number to Solage. Format is nnnnnn.
Product Number -
001
The FDA assigned number to identify Solage. Each strength is a separate product. May repeat for multiple part products. Format is nnn.
Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.
Approval Date -
Dec 10, 1999
The date Solage was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".
Reference Listed Drug (RLD) -
Yes
The pioneer or innovator of Solage. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.
Type -
RX
The group or category of approved drugs Solage is in. Format is RX, OTC, DISCN.
Applicant Full Name -
Barrier Therapeutics
The full name of the firm holding legal responsibility for the new application of Solage.
Solage
|